Pyridostigmine Bromide (Pyridostigmine Bromide) Patent Expiration, LOE Window & CMS Spending

Pyridostigmine Bromide (Pyridostigmine Bromide) by United States Army Office Surgeon General: FDA Orange Book LOE 2038-06-18, 6 AB generics, $25.8M 2024 CMS Part D & Medicaid spend, and 1 CA HCAI SB 17 wholesale price filings.

Regulatory & Reimbursement Dimension Verified Value
Consolidated SponsorUnited States Army Office Surgeon General
FDA Application & PathwayN020414 (NDA)
Exclusivity / Cliff HorizonLong-Dated Protection (2036+)
Core Active-Ingredient LOE DateNot listed / N/A
Last Listed Patent or Exclusivity Date2038-06-18
Orange Book Patents (*PED Extensions)9 patents (0 *PED)
Active AB-Rated Generic Competitors6
2024 CMS Total Public Spend$25.8M
2024 Medicare Part D Spend$21.6M
2024 Medicaid Spend$4.2M
Reported Wholesale Price Change (CA SB 17)1 WAC filings (max 12.1% 2-yr change)